Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Buchholz TA, et al. Among authors: hortobagyi gn. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):880-8. doi: 10.1016/s0360-3016(02)02850-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095553
Hormonal therapy with tamoxifen in male breast cancer.
Hortobagyi GN, DiStefano A, Legha SS, Buzdar AU, Blumenschein GR. Hortobagyi GN, et al. Cancer Treat Rep. 1979 Apr;63(4):539-41. Cancer Treat Rep. 1979. PMID: 221118 No abstract available.
Rubidazone in metastatic breast cancer.
Legha SS, Benjamin RS, Buzdar AU, Hortobagyi GN, Blumenschein GR. Legha SS, et al. Among authors: hortobagyi gn. Cancer Treat Rep. 1979 Jan;63(1):135-6. Cancer Treat Rep. 1979. PMID: 369685 Clinical Trial. No abstract available.
1,108 results